2025-07-13 - Analysis Report
Okay, here's an analysis of Transmedics Group Inc. (TMDX) based on the data provided.

**Report on Transmedics Group Inc. (TMDX)**

**1. Performance Overview**

*   **Ticker:** TMDX
*   **Company Description:** Transmedics Group Inc. is a medical technology company pioneering a novel approach to improve organ transplant therapy for end-stage organ failure patients.

**Key Performance Metrics:**

*   **TMDX Cumulative Return:** 229.86%
*   **S&P 500 (VOO) Cumulative Return:** 67.03%
*   **Absolute Deviation (TMDX - VOO):** 171.4
*   **Deviation Range:** Max: 296.4, Min: -64.2
*   **Relative Deviation:** 65.3

**Analysis:** TMDX has significantly outperformed the S&P 500 (VOO) over the period examined. The cumulative return difference is substantial (171.4%). The relative deviation of 65.3 suggests that TMDX's outperformance is positioned in the upper range of its historical performance relative to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD   | Alpha   | Beta   | Cap(B) |
|------------|--------|-------|---------|--------|--------|
| 2019-2021  | -4.0%  | 63.4% | -52.0%  | 0.0    | 0.7    |
| 2020-2022  | 140.0% | 68.3% | 138.0%  | 0.1    | 2.1    |
| 2021-2023  | 95.0%  | 69.4% | 77.0%   | 0.2    | 2.7    |
| 2022-2024  | 147.0% | 82.8% | 121.0%  | 0.2    | 2.1    |
| 2023-2025  | 111.0% | 82.8% | 64.0%   | 0.5    | 3.8    |

**Analysis:**

*   **CAGR (Compound Annual Growth Rate):** CAGR fluctuates significantly from -4.0% to 147.0%, indicating high growth variability.
*   **MDD (Maximum Drawdown):** High MDD values (63.4% to 82.8%) suggest significant downside risk.
*   **Alpha:** Consistently positive alpha values indicate that TMDX has generated excess returns compared to its benchmark, especially in 2020-2024.
*   **Beta:** Beta values range from 0.0 to 3.8, showing TMDX's volatility relative to the market has varied significantly over time. Higher beta values (e.g., 3.8 in 2023-2025) suggest higher volatility.

**2. Recent Price Action**

*   **Current Price:** 112.46
*   **Previous Close:** 124.78
*   **Change:** -9.87
*   **5-Day Moving Average:** 122.71
*   **20-Day Moving Average:** 129.75
*   **60-Day Moving Average:** 117.84

**Analysis:** TMDX has experienced a significant price drop recently (-9.87). The 5-day and 20-day moving averages are above the current price, suggesting a potential downtrend. The price is below the 60-day moving average, which further indicates a short-term negative momentum. The large negative change reflects a significant and potentially concerning shift in market sentiment.

**3. Market Risk Indicators and Outlook**

*   **Market Risk Indicator (MRI):** 0.3294 (Low Risk)
*   **RSI:** 38.75 (approaching oversold)
*   **PPO:** -1.83 (negative momentum)
*   **Hybrid Signal:** cash_69%_Sell 0.7% of holdings (4 shares - Caution - MRI:0.35)
*   **Change in Relative Deviation (20-day):** -0.6 (short-term decline)
*   **Expected Return:** 53.3% (long-term, relative to S&P 500)

**Analysis:**

*   The MRI indicates low risk.
*   The RSI of 38.75 suggests that the stock is nearing oversold conditions, which might signal a potential rebound.
*   The negative PPO confirms the current downward momentum.
*   The Hybrid Signal suggests a cautious approach, recommending a slight reduction in holdings and a high cash ratio.
*   The negative change in relative deviation confirms a recent short-term decline.
*   The expected return of 53.3% is highly optimistic, suggesting significant long-term outperformance potential compared to the S&P 500.

**4. Recent News & Significant Events**

*   **[2025-07-11]:** Major business developments, regulatory changes, or market events.
*   **[2025-07-10]:** Analysts discussing performance and outlook in the context of industry trends and global economic factors.
*   **[2025-07-13]:** Notable stock volatility influenced by recent news, earnings reports, or executive actions.
*   **[2025-07-12]:** Market experts highlighting both risks and opportunities, advising investors to monitor news and announcements.

**Analysis:** The news suggests that TMDX is experiencing significant activity and attention. The volatility warning is consistent with the recent price drop. Monitoring news and company announcements is crucial.

**5. Recent Earnings Analysis**

| Date       | EPS  | Expected EPS |
|------------|------|--------------|
| 2025-05-08 | 0.70 | 0.29         |
| 2025-02-27 | 0.19 | 0.22         |
| 2024-10-28 | 0.12 | 0.29         |
| 2024-07-31 | 0.35 | 0.21         |
| 2024-04-30 | 0.35 | 0.03         |

**Analysis:** TMDX has generally exceeded EPS expectations in recent quarters, with a notable outperformance in the most recent quarter (2025-05-08). This indicates strong financial performance and positive growth momentum.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue  | Profit Margin |
|------------|----------|---------------|
| 2025-03-31 | $0.14B   | 61.47%        |
| 2024-12-31 | $0.12B   | 59.21%        |
| 2024-09-30 | $0.11B   | 55.94%        |
| 2024-06-30 | $0.11B   | 60.59%        |
| 2024-03-31 | $0.10B   | 61.91%        |

**Capital and Profitability:**

| Quarter    | Equity   | ROE     |
|------------|----------|---------|
| 2025-03-31 | $0.27B   | 9.64%   |
| 2024-12-31 | $0.23B   | 3.00%   |
| 2024-09-30 | $0.21B   | 2.01%   |
| 2024-06-30 | $0.19B   | 6.42%   |
| 2024-03-31 | $0.16B   | 7.65%   |

**Analysis:**

*   **Revenue:** Revenue is consistently growing, indicating strong sales performance.
*   **Profit Margin:** High and stable profit margins (around 60%) suggest efficient operations.
*   **Equity:** Equity is increasing, reflecting positive capital accumulation.
*   **ROE (Return on Equity):** ROE shows variability, with the latest quarter showing a strong increase. This suggests improved profitability relative to equity.

**7. Overall Assessment**

Transmedics Group Inc. (TMDX) has demonstrated significant outperformance compared to the S&P 500, with a high cumulative return difference. Recent earnings have exceeded expectations, and revenue and profit margins are strong.

However, there are some concerning signals:

*   **Recent Price Drop:** The significant price drop and negative short-term moving averages suggest a potential downtrend.
*   **High Volatility:** High MDD values and fluctuating Beta values indicate high volatility.
*   **Hybrid Signal Caution:** The hybrid signal recommends caution and a higher cash position.

**Recommendation:**

Given the recent price drop and cautious signals, it's crucial to carefully monitor TMDX. The positive long-term expected return and strong financial performance suggest potential for future growth, but the volatility and recent negative momentum warrant a cautious approach. Investors should closely follow company news and industry developments before making any investment decisions.
